Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Inovio reports strong immune responses with VGX-3100 vaccine for cervical dysplasia and cancer

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, has reported data demonstrating long-term durability of T cell immune responses of up to over two years (at the latest time measured) in 7 of 8 evaluated patients following a fourth vaccination of VGX-3100, its investigational SynCon® DNA vaccine for treating cervical dysplasia and cancer caused by human papillomavirus (HPV) that is delivered using intramuscular electroporation.

15 Jul 2011

Study: Bone marrow transplant offers new hope for patients with high-risk leukemia

Bone marrow transplant survival more than doubled in recent years for young, high-risk leukemia patients treated at St. Jude Children's Research Hospital, with patients who lacked genetically matched donors recording the most significant gains. The results are believed to be the best ever reported for leukemia patients who underwent bone marrow transplantation.

15 Jul 2011

Berks County's Department of Health advises public about possible measles exposure

The state Department of Health is advising the public of a possible case of measles exposure in Morgantown, Berks County.

15 Jul 2011

Seattle Children's inaugurates new center for cancer research

Today, Seattle Children's Research Institute announced the opening of the Center for Childhood Cancer Research.

15 Jul 2011

CLEOPATRA Phase III study on HER2-positive mBC meets primary endpoint

Genentech, a member of the Roche Group, today announced that CLEOPATRA, a pivotal Phase III study, met its primary endpoint.

15 Jul 2011

Lansing Community College to launch unique program for ex-military medics

Lansing Community College – after two years of planning – is set to launch a unique medical program that will give a well-earned boost to men and women who served as military medics.

15 Jul 2011

Non-invasive 'swine flu' breath test could help ease future vaccine shortages

A test, novel breath measuring the immune response to the H1N1 flu virus, could help to ease future vaccine shortages by identifying the people who have already been infected with the flu virus.

15 Jul 2011

Tea or coffee can protect from MRSA superbug

According to the latest study in the Annals of Family Medicine, people who drink tea or coffee regularly may be less likely to carry the Methicillin-resistant Staphylococcus aureus (MRSA) infection in their nostrils.

14 Jul 2011

Safety guidelines for preventing injuries from gasoline

Summer is in full swing and injuries from gasoline and other accelerants are on the rise. The University of Michigan Health System's Trauma Burn Center saw 14 such burns in the past month.

14 Jul 2011

Positive data from Inovio's VGX-3400X Phase I study against H5N1 influenza

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that significant T cell and antibody responses were generated in its Phase I clinical study of VGX-3400X, a SynCon DNA vaccine for the prevention of avian H5N1 influenza delivered using intramuscular (IM) electroporation.

14 Jul 2011

'Sex' between viruses can create new influenza pandemic

A new University of Maryland-led study finds that 'sex' between the virus responsible for the 2009 flu pandemic (H1N1) and a common type of avian flu virus (H9N2) can produce offspring -- new combined flu viruses -- with the potential for creating a new influenza pandemic.

14 Jul 2011

New Tamiflu anti-viral flu medication in lower concentration

When flu season arrives this fall, a liquid form of Tamiflu—the most widely used anti-viral flu medication—will be available in a new, lower concentration to reduce the possibility of medication errors.

14 Jul 2011

Eisai's DACOGEN sNDA for acute myeloid leukemia accepted by FDA for review

SuperGen, Inc., a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced that Eisai Inc. today released information that the U.S. Food and Drug Administration (FDA) has accepted for review its supplemental New Drug Application (sNDA) seeking approval of DACOGEN (decitabine) for injection in the treatment of acute myeloid leukemia.

14 Jul 2011

Chimerix initiates CMX001 Phase 2 study for prevention of adenovirus disease following HSCT

Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, today announced that patient dosing has begun in the AdV HALT Trial (A Randomized, Placebo-Controlled, Multi-site Phase 2 Study Evaluating the Safety and Efficacy of Preemptive Treatment with CMX001 for the Prevention of Adenovirus Disease Following Hematopoietic Stem Cell Transplantation [HSCT]).

14 Jul 2011

Patient-centered medical home boosts diabetes outcomes, health

A health-care delivery model called patient-centered medical home (PCMH) increased the percentage of diabetes patients who achieved goals that reduced their sickness and death rates, according to health researchers.

14 Jul 2011

Adamis receives European patent for novel cell-based cancer vaccine technology

Adamis Pharmaceuticals Corporation, today announced the technology which constitutes the basis of a novel cell-based cancer vaccine, TeloB-VAX, was recently granted a patent in Europe.

14 Jul 2011

Swine flu vaccine and risk of Guillain-Barré Syndrome

In a large five nation study from Europe it was seen that the use of adjuvanted vaccines against the pandemic H1N1 influenza virus probably did not increase the risk of Guillain-Barré Syndrome (GBS), but the investigators could not firmly rule out a slightly greater chance of suffering the paralytic condition.

13 Jul 2011

Gates Foundation's Grand Challenges Explorations increases investments in bold innovative ideas

The Bill & Melinda Gates Foundation today announced that twelve grantees have advanced to the next level of Grand Challenges Explorations (GCE), an initiative that enables researchers worldwide to test unorthodox ideas that address persistent health and development challenges. The grantees will receive additional funding to continue Phase II of their research over a two-year period.

13 Jul 2011

FDA accepts Eisai's DACOGEN sNDA for review to treat acute myeloid leukemia

Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review its supplemental New Drug Application (sNDA) seeking approval of DACOGEN (decitabine) for injection in the treatment of acute myeloid leukemia.

13 Jul 2011

Three factors contribute to systemic scleroderma-related work disability

Systemic scleroderma has slowed Tracy Zinn but it has not stopped her from working. Thanks in part to determination and an accommodating employer, Zinn is now in her 13th year as an account executive for a firm that produces educational software. But, many with the incapacitating disease are not as fortunate.

13 Jul 2011

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Inovio reports strong immune responses with VGX-3100 vaccine for cervical dysplasia and cancer

Study: Bone marrow transplant offers new hope for patients with high-risk leukemia

Berks County's Department of Health advises public about possible measles exposure

Seattle Children's inaugurates new center for cancer research

CLEOPATRA Phase III study on HER2-positive mBC meets primary endpoint

Lansing Community College to launch unique program for ex-military medics

Non-invasive 'swine flu' breath test could help ease future vaccine shortages

Tea or coffee can protect from MRSA superbug

Safety guidelines for preventing injuries from gasoline

Positive data from Inovio's VGX-3400X Phase I study against H5N1 influenza

'Sex' between viruses can create new influenza pandemic

New Tamiflu anti-viral flu medication in lower concentration

Eisai's DACOGEN sNDA for acute myeloid leukemia accepted by FDA for review

Chimerix initiates CMX001 Phase 2 study for prevention of adenovirus disease following HSCT

Patient-centered medical home boosts diabetes outcomes, health

Adamis receives European patent for novel cell-based cancer vaccine technology

Swine flu vaccine and risk of Guillain-Barré Syndrome

Gates Foundation's Grand Challenges Explorations increases investments in bold innovative ideas

FDA accepts Eisai's DACOGEN sNDA for review to treat acute myeloid leukemia

Three factors contribute to systemic scleroderma-related work disability

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Newsletters you may be interested in